Two Sigma Investments, LP Gilead Sciences, Inc. Call Options Transaction History

Two Sigma Investments, LP

$41.1 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $5.07 Million - $5.76 Million	-78,200 Reduced 46.77%	89,000 $6.46 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $744,590 - $803,330	-11,000 Reduced 6.17%	167,200 $11.7 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $17.8 Million - $19.5 Million	-281,000 Reduced 61.19%	178,200 $12.3 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $22.1 Million - $25.2 Million	367,600 Added 401.31%	459,200 $29.7 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $12.6 Million - $14.4 Million	-222,800 Reduced 70.87%	91,600 $5.34 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $14.4 Million - $18.1 Million	232,400 Added 283.41%	314,400 $19.9 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.43 Million - $2.82 Million	33,600 Added 69.42%	82,000 $6.31 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $745,297 - $954,618	11,900 Added 32.6%	48,400 $3.62 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $11.4 Million - $12.5 Million	-184,900 Reduced 83.51%	36,500 $2.37 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $5.79 Million - $6.4 Million	92,700 Added 72.03%	221,400 $14 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $8.07 Million - $9.05 Million	-130,400 Reduced 50.33%	128,700 $8.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $11.4 Million - $12.8 Million	183,100 Added 240.92%	259,100 $16.8 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $3.39 Million - $4.42 Million	56,000 Added 280.0%	76,000 $4.75 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $20 Million - $22.2 Million	-281,200 Reduced 93.36%	20,000 $1.54 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $14.4 Million - $16.8 Million	221,600 Added 278.39%	301,200 $21.3 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $4.56 Million - $5.56 Million	62,600 Added 368.24%	79,600 $6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $2.7 Million - $3.17 Million	-38,000 Reduced 69.09%	17,000 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.97 Million - $4.7 Million	55,000	55,000 $4.46 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.64 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.38 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.05 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.96 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account